Log in
NYSE:TFX

Teleflex Stock Forecast, Price & News

$335.03
-16.43 (-4.67 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$334.82
Now: $335.03
$346.33
50-Day Range
$326.70
MA: $353.80
$389.47
52-Week Range
$221.27
Now: $335.03
$409.27
Volume284,215 shs
Average Volume249,723 shs
Market Capitalization$15.58 billion
P/E Ratio32.98
Dividend Yield0.39%
Beta1.03
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products consist of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management for patients in the hospital and individuals in the home care markets. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Read More
Teleflex logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.71 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800
Employees14,400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$14.88 per share
Book Value$64.35 per share

Profitability

Net Income$461.47 million

Miscellaneous

Market Cap$15.58 billion
Next Earnings Date10/29/2020 (Confirmed)
OptionableOptionable
$335.03
-16.43 (-4.67 %)
(As of 10/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teleflex (NYSE:TFX) Frequently Asked Questions

How has Teleflex's stock price been impacted by Coronavirus (COVID-19)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TFX shares have decreased by 2.1% and is now trading at $335.03.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Teleflex?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Teleflex
.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, July, 30th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.25 by $0.68. The medical technology company earned $567 million during the quarter, compared to the consensus estimate of $537.85 million. Teleflex had a return on equity of 17.15% and a net margin of 18.99%. Teleflex's revenue for the quarter was down 13.1% on a year-over-year basis. During the same quarter last year, the business posted $2.66 EPS.
View Teleflex's earnings history
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, July 30th. Stockholders of record on Friday, August 14th will be given a dividend of $0.34 per share on Tuesday, September 15th. This represents a $1.36 annualized dividend and a yield of 0.41%. The ex-dividend date is Thursday, August 13th.
View Teleflex's dividend history
.

What price target have analysts set for TFX?

10 brokers have issued 12 month target prices for Teleflex's shares. Their forecasts range from $275.00 to $440.00. On average, they expect Teleflex's share price to reach $389.40 in the next year. This suggests a possible upside of 16.2% from the stock's current price.
View analysts' price targets for Teleflex
.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Chairman, Pres & CEO (Age 53, Pay $2.33M)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 58, Pay $1.2M)
  • Mr. James J. Leyden, Corp. VP, Gen. Counsel & Sec. (Age 53, Pay $591.92k)
  • Mr. Cameron P. Hicks, Corp. VP of HR & Communications (Age 55, Pay $557.86k)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, VP & Chief Information Officer
  • Mr. Jacob P. Elguicze, Treasurer & VP of Investor Relations (Age 47)
  • Ms. Gwen Chapman, Chief Compliance Officer & Corp. VP (Age 45)
  • Ms. Gwendolyn Ann Watanabe, Corp. VP of Global Corp. Devel., Strategy and Strategic Partnerships (Age 49)
  • Mr. David R. Amerson, Pres & GM of Interventional Urology

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by many different institutional and retail investors. Top institutional shareholders include Villere ST Denis J & Co. LLC (0.46%), AMI Asset Management Corp (0.26%), Retirement Systems of Alabama (0.21%), Mountain Pacific Investment Advisers Inc. ID (0.16%), Scout Investments Inc. (0.10%) and Braun Stacey Associates Inc. (0.09%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends for Teleflex
.

Which institutional investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including Villere ST Denis J & Co. LLC, Scout Investments Inc., State of Alaska Department of Revenue, AMI Asset Management Corp, Standard Life Aberdeen plc, Nisa Investment Advisors LLC, KBC Group NV, and Tributary Capital Management LLC. Company insiders that have sold Teleflex company stock in the last year include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Stephen K MD Klasko, and Thomas E Powell.
View insider buying and selling activity for Teleflex
.

Which institutional investors are buying Teleflex stock?

TFX stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Retirement Systems of Alabama, Conestoga Capital Advisors LLC, CWM LLC, Bradley Foster & Sargent Inc. CT, Envestnet Asset Management Inc., Buffington Mohr McNeal, and Ingalls & Snyder LLC.
View insider buying and selling activity for Teleflex
.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $335.03.

How big of a company is Teleflex?

Teleflex has a market capitalization of $15.58 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.